目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Application
Market segments
Comparison by Application
Preclinical drug development - Market size and forecast 2020-2025
Bio marker analysis - Market size and forecast 2020-2025
Market opportunity by Application

Customer landscape
Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Champions Oncology Inc.
Charles River Laboratories International Inc.
Experimental Pharmacology and Oncology EPO Berlin Buch GmbH
Hera Biolabs Inc.
Oncodesign SA
PerkinElmer Inc.
Pharmatest Services Oy
The Jackson Laboratory
UROSPHERE SAS
WuXi AppTec Co. Ltd.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Application - Market share 2020-2025 (%)
22: Comparison by Application
23: Preclinical drug development - Market size and forecast 2020-2025 ($ million)
24: Preclinical drug development - Year-over-year growth 2020-2025 (%)
25: Bio marker analysis - Market size and forecast 2020-2025 ($ million)
26: Bio marker analysis - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Application
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Champions Oncology Inc. - Overview
48: Champions Oncology Inc. - Business segments
49: Champions Oncology Inc. - Key offerings
50: Champions Oncology Inc. - Key customers
51: Champions Oncology Inc. - Segment focus
52: Charles River Laboratories International Inc. - Overview
53: Charles River Laboratories International Inc. - Business segments
54: Charles River Laboratories International Inc. - Key offerings
55: Charles River Laboratories International Inc. - Key customers
56: Charles River Laboratories International Inc. - Segment focus
57: Experimental Pharmacology and Oncology EPO Berlin Buch GmbH - Overview
58: Experimental Pharmacology and Oncology EPO Berlin Buch GmbH - Product and service
59: Experimental Pharmacology and Oncology EPO Berlin Buch GmbH - Key offerings
60: Experimental Pharmacology and Oncology EPO Berlin Buch GmbH - Key customers
61: Experimental Pharmacology and Oncology EPO Berlin Buch GmbH - Segment focus
62: Hera Biolabs Inc. - Overview
63: Hera Biolabs Inc. - Product and service
64: Hera Biolabs Inc. - Key offerings
65: Hera Biolabs Inc. - Key customers
66: Hera Biolabs Inc. - Segment focus
67: Oncodesign SA - Overview
68: Oncodesign SA - Product and service
69: Oncodesign SA - Key offerings
70: Oncodesign SA - Key customers
71: Oncodesign SA - Segment focus
72: PerkinElmer Inc. - Overview
73: PerkinElmer Inc. - Business segments
74: PerkinElmer Inc. - Key offerings
75: PerkinElmer Inc. - Key customers
76: PerkinElmer Inc. - Segment focus
77: Pharmatest Services Oy- Overview
78: Pharmatest Services Oy- Product and service
79: Pharmatest Services Oy- Key offerings
80: Pharmatest Services Oy- Key customers
81: Pharmatest Services Oy- Segment focus
82: The Jackson Laboratory - Overview
83: The Jackson Laboratory - Business segments
84: The Jackson Laboratory - Key offerings
85: The Jackson Laboratory - Key customers
86: The Jackson Laboratory - Segment focus
87: UROSPHERE SAS - Overview
88: UROSPHERE SAS - Product and service
89: UROSPHERE SAS - Key offerings
90: UROSPHERE SAS - Key customers
91: UROSPHERE SAS - Segment focus
92: WuXi AppTec Co. Ltd. - Overview
93: WuXi AppTec Co. Ltd. - Business segments
94: WuXi AppTec Co. Ltd. - Key offerings
95: WuXi AppTec Co. Ltd. - Key customers
96: WuXi AppTec Co. Ltd. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations